In conclusion, the present study demonstrated that administration of octreotide inhibited hepatic HO-1 overexpression in cirrhotic rats, reduced hepatic HO-1 expression levels, relieved liver injury and attenuated liver fibrosis. The gene discussed is HMOX1; the disease is Hepatic fibrosis.